Drug
Strontium ranelate clinical trials
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2005
How studies write it
Studies that test it under each name
Name
Brand
Combined with it in one product
Studies by the year they started
6 studies that test it; most in 2005 (1)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2018 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 4
- 5
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 4
Mansoura University (1) · Medical University of Vienna (1) · University of Valencia (1) · Nycomed (1) · Eli Lilly and Company (1) · Aga Khan University Hospital, Pakistan (1)
Often tested with
Tested in the same studies.
Calcium (1) · Vitamin D (1) · Raloxifene (1) · Parathyroid Hormone (1) · Teriparatide (1)
Studies
Open first, then newest update. How each study uses strontium ranelate is read from its arms, and is right about nine times in ten.
Testing it · 6
- Role of Strontium Ranelate in Proximal Femur Fragility Fractures.Status unknownPhase 4Aga Khan University Hospital, PakistanNCT05712616Written as Strontium Ranelate
- Strontium Ranelate and KOACompletedNot applicableMansoura UniversityNCT03937518Written as Strontium Ranelate
- Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium RanelateCompletedPhase 4Medical University of ViennaNCT01222026Written as Strontium Ranelate + Ca/Vitamin-D
- Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal OsteoporosisCompletedPhase 4University of ValenciaNCT01544894Written as Strontium ranelate
- Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM)CompletedPhase 4NycomedNCT00479037Written as Strontium Ranelate
- Teriparatide and Strontium Ranelate Head-To-Head Comparison TrialCompletedPhase 4Eli Lilly and CompanyNCT00239629Written as Strontium ranelate
Codes
What other systems call strontium ranelate · ClinicalTrials.gg INT003730
- MeSH (NLM) C081587strontium ranelateConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 04NQ160FRUSTRONTIUM RANELATEConfirmed FDA, NLM, Wikidata
- Wikidata Q419215strontium ranelateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C93265Strontium RanelateOne source FDA
- DrugBank DB09267One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C081587 | strontium ranelate | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 04NQ160FRU | STRONTIUM RANELATE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q419215 | strontium ranelate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C93265 | Strontium Ranelate | One source FDA |
| DrugBank | DB09267 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.